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Summary / Abstract 
Objective: Bicuspid aortic valve (BAV) disease is one of the most common congenital cardi-
ac defects found in the general population and seems to be associated with an increased risk 
of intracranial aneurysms. Being a connective tissue disorder, it has been suspected to be 
associated with defects in the connective tissue of arterial walls, since similar diseases such 
as polycystic kidney disease, Marfan syndrome or Ehlers-Danlos syndrome have already 
been proven to increase the risk for intracranial aneurysmal occurrence. In order to demon-
strate a possible association of the two entities a patient collective with BAV was screened 
using magnetic resonance imaging (MRI) scanning for aneurysmal detection. 
Methods: MRI imaging in order to obtain a threedimensional time-of-flight (3D TOF) Angi-
ography was performed on 60 patients with known BAV (age 30-60 years (mean 51.7 
years)). Previous medical history, clinical examination, inclusion and exclusion criteria, risk 
factors for aneurysmal disease and current medication were documented.   
Results: None of the BAV patients screened presented with an intracranial aneurysm (95% 
confidence interval 0.0%-5.5%), only one was detected extracranially. Compared to the 
overall prevalence of unruptured intracranial aneurysms in the general population 3.2% (95% 
confidence interval 1.9%-5.2%)  (meta-analysis of 68 studies on 83 study populations, includ-
ing 94 912 patients from 21 countries) and a study done by Schievink et al. with a similar 
cohort of 61 patients which revealed with 9.8% (95% confidence interval 2.4%-17.3%) a 
higher incidence of intracranial aneurysms in patients with BAVs, our patient cohort did not 
show an increased risk for aneurysmal disease.  
Conclusion: In this study no association of intracranial aneurysms in patients with bicuspid 











Einleitung: Bikuspide Aortenklappen stellen die häufigste kardiale Fehlbildung in der Bevöl-
kerung dar und scheinen mit einem erhöhten Risiko für das Vorkommen intrakranieller Aneu-
rysmata verbunden zu sein. Diese angeborene kardiale Fehlbildung zählt zu der Gruppe der 
Bindegewebserkrankungen. Daher wird vermutet, dass zusätzlich zu dem Klappendefekt ein 
Defekt im Bindegewebe der arteriellen Gefäßwände vorliegen könnte. Insbesondere da be-
reits gezeigt werden konnte, dass andere Bindegewebserkrankungen, wie die polyzystische 
Nierenerkrankung, das Marfan-Syndrom oder das Ehler-Danlos-Syndrom, mit einem erhöh-
ten Vorkommen intrakranieller Aneurysmata verbunden sind. Um eine Assoziation beider 
Pathologien zu untersuchen, erfolgte mithilfe einer kernspintomographischen Bildgebung des 
Kopfes das Screening von 60 Patienten. 
Methoden: Zur Detektion einer möglichen Gefäßmalformation erfolgte die Durchführung 
einer dreidimensionalen Time-of-flight Sequenz Angiographie an 60 Patienten mit diagnosti-
zierter bikuspider Aortenklappe im Alter zwischen 30 und 60 Jahren (Durchschnittsalter 51,7 
Jahren). Vorerkankungen, eine neurologische körperliche Untersuchung, Einschluss und 
Ausschlusskriterien, Risikofaktoren für die Begünstigung der Entwicklung eines intrakraniel-
len Aneurysmas sowie die aktuelle Dauermedikation wurden dokumentiert. 
Ergebnisse: Bis auf ein extrakraniell lokalisiertes Aneurysma, konnte kein intrakranielles 
Aneurysma (Konfidenzinterval 95 % (0,0%; 5,5%)) im untersuchten Patientenkollektiv gefun-
den werden. Verglichen mit der allgemeinen Prävalenz nicht rupturierter Aneurysmata in der 
Normalbevölkerung, welche bei 3,2% (Konfidenzinterval 95% (1,9%; 5,2%)) liegt (laut einer 
Metaanalyse, welche 68 Studien, 83 verschiedener Bevölkerungen, 94 912 Patienten aus 21 
verschiedenen Ländern umfasst) wurde keine höhere Inzidenz bei Patienten mit bikuspider 
Aortenklappe in dieser Studie gefunden. Dies steht im Gegensatz zu einer Studie von 
Schievink et al., die eine ähnliche Patientenkohorte bestehend aus 61 Patienten mit bikuspi-
der Aortenklappe untersuchte und ein höheres Vorkommen (9,8%,  Konfidenzinterval 95% 
(2,4%; 17,3%)) von intrakraniellen Aneurysmata fand.  
Schlussfolgerung: In dieser Studie war das Vorkommen intrakranieller Aneurysmata bei 
Patienten mit bikuspiden Aortenklappen nicht erhöht. Daher konnte in dieser Arbeit keine 








2.1. Definition, general and gender specific prevalence and aortopathy of 
bicuspid aortic valves 
Bicuspid aortic valves (BAV) are not only one of the most common congenital cardiac mal-
formations5,19,31,57,58,77 and the leading congenital cause of aortic valve stenosis, but are also 
associated with an increased risk of aneurysmal disease. Its general prevalence has found to 
be 1-2 % in the general population5,19,31,57,58,77 with a predominance for the male gender 
(male to female ratio 3:1)20,40,68 with also a higher complication rate in men (i.e. occurrence of 
aortic regurgitation and aortic dissection).40  
Bicuspid aortic valves consist of two instead of three, unequally sized cusps, due to an in-
complete separation during embryogenesis. Only in recent years, it has become clear, that 
this valve malformation is far more complex than initially suspected and multiple subtypes 
have been identified.49 The most updated classification of BAVs by Sievers and Schmidtke67  
differentiates not only between the morphological but also the functional characteristics of the 
malformed valve and between valves with or without raphe and the precise location of the 
fused cusps (e.g. L-R= left and right cusp fusion or R-N= right to non-coronary cusp fusion). 
The complexity of this classification reflects on the heterogenicity of this pathology. 
The genesis of aortopathy associated with BAVs has so far not been definitively identified, 
however, genetic mutations are thought to play an important role.49 For example, the chro-
mosome 15q25-26 has been implicated in the genesis of thoracic aortal aneurysms in BAV 
patients49 or the NOTCH1 gene23 has been associated with aortic dilatation in congenital 
bicuspid aortic valve disease. Yet, the exact number of genes, their specific role and if the 
same genes responsible for the development of the BAV are also causing BAV associated 
aortopathy is not fully understood at this point.49 
 
2.2. Definitions, types and pathogenesis and pathologic features of intracranial aneu-
ryms   
Aneurysms are defined as an abnormal, localized dilatation of a vessel wall. Generally, three 
types of aneurysms are differentiated: true, false and dissecans. 
True aneurysms are a dilatation of all three layers of the vessel wall, with the wall itself still 
being intact. They vary in size: the diameter of small aneurysms doesn’t exceed more than 5 
mm, medium to large aneurysms are between 6 and 25 mm and a diameter greater than 25 
mm classifies as large. True aneurysms are classified according to their morphology since 
this is relevant for their treatment. If shaped like a sphere, they are called saccular aneu-
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rysms, if the dilatation comprises a longer segment of the artery and is diffuse, they are 
named fusiform aneurysms. The saccular aneurysm is the most commonly found intracranial 
aneurysm and often contains thrombotic material. Due to its typical localization at arterial 
bifurcations of the circle of Willis (e.g. at the anterior and posterior communicating arteries, 
the internal carotid artery, the middle cerebral artery and the basilar artery), it is the most 
frequent cause of subarachnoid haemorrhage (85%).15 
In false aneurysms a defect in the vessel wall causes blood to accumulate and form a hae-
matoma externally soley bound by extravascular connective tissue.  
Cases where blood has separated the layers of the vessel wall and formed a hematoma are 
classified as a dissection (aneurysma dissecans).  
There is evidence that two main factors are implicated in the pathogenesis of intracranial 
aneurysms: genetics and acquired risk factors. 
A familial aggregation of intracranial aneurysms was first described in 1954 by Chambers et 
al.11  and also more recent studies, analyzing large patient collectives, like Wills et al.81 (364 
Finnish families) were able to provide reliable evidence that a positive family history and 
therefore genetics must be involved in their development.81 There have been estimations of 
an increased risk for first-degree relatives of patients with intracranial aneurysms of as high 
as 9.8 %. 81 Likewise, an increased risk for subarachnoid haemorrhage in cases of positive 
family history has been shown.10 Furthermore a positive family history for brain tumors, pitui-
tary adenoma and atherosclerosis have also been linked.76 With the fact, that heritable con-
nective tissue diseases have also been associated with aneurysmal disease will be dealt 
later in this chapter.  
Pathophysiologically, defects of one of the vessel layers or the lack of closure of remnant 
vessel residues during embryogenesis are known causes of congenital aneurysmal disease.  
Amongst the acquired risk factors arterial hypertension is most commonly connected with the 
presence of an unruptured intracranial aneurysm, followed by advanced age, cigarette use, 
female gender, diabetes, coronary artery disease and alcohol consumption.36  
The acquired risk factors gender and age deserve emphasis at this point. Gender specific 
differences were demonstrated with a higher prevalence (6%) of unruptured intracranial an-
eurysms in the female gender with a male to female prevalence ratio of 1.57.76  Another 
study evaluating 10,259 autopsies found a female to male ratio of unruptured intracranial 
aneurysms to be 53:31.33  
8 
It should be noted here as well, that also the incidence of subarachnoid haemorrhage is with 
1.24 times higher in women than in men as well as its secondary complications (risk factor 
“female gender” for vasospasms: Odds ratio 1.5).13,15,72,76  These sex related differences ap-
ply especially for age groups of advanced age.72 While in both genders the incidence of an-
eurysms increases with an age over 30 years36,76, this incidence is even more pronounced 
for women, when looking at the advanced age group (age < 50). In males such a significant 
incline was not found. So in summary, in the age group over 50, the gender differences be-
come even more emphasised.72,76 A decrease of the overall oestrogen level after menopause 
und a consecutive decrease of oestrogen receptors has been implicated in this pathophysi-
ology.29,32,76 
Interestingly, different acquired risk factors can be attributed to certain aneurysmal localiza-
tions and therefore varying underlying pathophysiologic mechanisms of intracranial aneu-
rysmal disease have been suspected.36 Even though Kang et al.36 showed an overall associ-
ation of arterial hypertension with aneurysms, in cases of medial cerebral artery aneurysms 
additionally acquired risk factors, namely age over 50 plus smoking, were present. In fe-
males, particularly after menopause, the most common aneurysmal sites were the internal 
carotid, the posterior communicating artery and the medial cerebral artery bifurcation. The 
hypothesis here is, that the decreased oestrogen levels have a pathophysiologic influence on 
the vessel walls.  No additional risk factors other than hypertensive disease were found in 
patients with aneurysms located in the posterior cerebral circuit, whereas smoking and ex-
cessive alcohol consumption were more common with aneuryms of the anterior communi-
cating artery.36 
 
2.3. The pathobiological hypothesis of rupture and the treatment of intracranial aneu-
rysms 
With a prevalence of 3 % in the general population, unruptured intracranial aneurysms of the 
saccular type are common lesions and are increasingly incidentally detected, due to the wide 
availability of magnetic resonance imaging.76 Even though data shows that aneurysms of 
small sizes (< 5-7 mm) are less likely to rupture34,69,79, the mortality rate of subarachnoid 
haemorrhage (its most frequent aetiology being a saccular intracranial aneurysm) is as high 
as 65 %79 and permanent posthaemorrhagic disabilities in surviving patients is 50 %.52  
But what are the mechanisms and the factors favoring a rupture? And how do we determine 
whether or not to recommend therapy to the patient? 
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Histopathological examinations of ruptured saccular aneurysms showed a thinned out or 
nonexistent tunica media and a damaged internal elastic lamina.4 There is evidence that 
complex chronic inflammatory processes predispose an aneurysm to rupture. Degenerative 
processes of the vessel wall with a decrease of wall stabilizing cells (i.e. mural cells) but an 
excess of myointimal fibrous tissue as well as constant remodeling processes resulting in a 
disorganized wall structure, have been identified.21,71  Vessel wall infiltration by immune cells 
(T- cells, macrophages) triggering a complex cascade leading to vessel wall fibrosis, luminal 
fibrosis and de-endothelialization are associated with rupture.21 
Despite extensive research however, the exact pathobiological mechanisms (their exact 
pathway and sequence) causing aneurysmal rupture, remain unknown.71 
Yet, there is scientific consensus regarding certain risk factors that should be taken into ac-
count when considering treatment options in an aneurysma patient. Several studies show 
that advanced age (age >60), female gender, Japanese and Finnish ethnicity, aneurysmal 
size (> 5 mm), aneurysmal location (posterior circulation) and symptomatic (vs. asymptomat-
ic) aneurysm are associated with a higher risk of rupture.78 
The German Association of Neurology (DGN) aids with scientifically based clear guidelines 
and recommends interventional treatment only for symptomatic aneurysms with mass effect, 
independent of aneurysmal size and for asymptomatic aneurysms in the anterior circulation 
that are at least 7 mm in diameter. For aneurysms in the anterior circulation that are smaller 
than 7 mm in diameter and are asymptomatic, without previous aneurysmal bleeding, inter-
ventional therapy is recommended to be optional. However, in cases of aneurysms located in 
the posterior circulation, interventional treatment is recommended independent of their size, 
if the comorbidities, the neurological status of the patient and the risks associated with an 
intervention, have been weighed against the interventional benefits for the patient. In patients 
with a positive family history, autosomal dominant polycystic kidney disease or monozygous 
twins, screening is stated as an option, but not definitively recommended.70  
 
2.4. Association of BAV (amongst other heritable connective tissue diseases) with 
aneurysmal disease (aortic and intracranial) 
Over the past few years, several studies were able to demonstrate, that the overall preva-
lence of aneurysmal disease seems to be much higher in patients with a connective tissue 
disorder.24,39,76 Vlak et al.76 compared 68 studies of 21 countries on the prevalence of unrup-
tured intracranial aneurysms and found a higher prevalence of intracranial aneurysms in pa-
tients with connective tissue disorders (such as autosomal dominant polycystic kidney dis-
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ease). Likewise this was demonstrated for Marfan`s syndrome (prevalence of intracranial 
aneurysm 14% and its dissection 3%), Ehlers-Danlos syndrome (12%), neurofibromatosis 
type 1 (11%) and Loeys-Dietz syndrome (28%).39 
Furthermore scientific data of patients with bicuspid aortic valves, classified as a connective 
tissue disease, shows an association with aneurysmal disease – both the aorta and the in-
tracranial vessels.  
Regardless of the haemodynamic turbulences from abnormal valve morphology9,28,53 a higher 
incidence of thoracic aortal aneurysms in patients with congenital bicuspid aortic valve dis-
ease has been established, as well as a higher complication rate from these aneurysms, 
such as rupture or dissections (8.4 % compared to patients without BAV).37,50,59 Also in 60% 
of BAV patients concomitant dilatation of the proximal aorta occurs28,37,59 and aneurysmal 
development for the next 25 years, even if not present at the time of BAV diagnosis, was 
calculated to be 26 %.50  In summary, coarctation, dilatation and aneurysms of the aorta (all 
being congenital vascular defects) are common comorbid findings in BAV patients74 and it 
should be noted as well, that patients with a coarctation of the aorta (regardless of the pres-
ence of a BAV) in turn carry a higher risk for intracranial aneurysms.22,54,61,65 
Additionally to an increased risk for aortal aneurysms, the same seems to be true for aneu-
rysms affecting the intracranial arterial system in patients with BAV. In a study done in the 
USA with a patient collective of 61 patients with known BAV, the incidence of an intracranial 
aneurysm was calculated to be 9.8 % higher compared to the general population.63 A more 
recent retrospective study including a larger patient collective (n= 678) found a prevalence of 
7.7 %, particularly in patients with aortic coarctation present (12.9%).18   
The evaluation of patients with known intracranial aneurysmal disease for the occurrence of 
bicuspid aortic valves by Goyal et al.27 using a large patient collective (n=217) resulted in a 
prevalence of 0.6%, therefore not underlining the findings of other studies postulating an as-
sociation of the two pathologies.18,63 But it showed a connection between intracranial and 
aortic aneurysmal occurrence (prevalence of 4.7%, regardless of the presence of a BAV).27 
Shaulov et al.66 were also not able to prove an association of the two pathologies in their 
patient cohort (n=56) however, they were looking at patients with ruptured aneurysms.  
So in conclusion, being classified as a connective tissue disease, bicuspid aortic valve dis-
ease is part of a group of pathologies which include the Marfan syndrome, polycystic kidney 
disease and the Ehlers-Danlos syndrome6  - all pathologies in which the connective tissue of 
the whole arterial system can be affected and for which an association with intracranial aneu-
rysms and dissections has already been demonstrated in literature.22,39,60-62,76 
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2.5. Screening methods for intracranial aneurysms 
While digital substraction angiography (DSA) is the goldstandard of aneurysmal detection 
and morphology assessment14,80 it is not routinely used as a screening method due to its 
invasiveness and risks. Exposure to ionizing radiation, nephrotoxicity from the contrast 
agent, persisting neurological deficits due to peri-interventional cerebral thromboembolisms 
and iatrogenic arterial vessel damage (particularly aneurysm spurium) account amongst the 
main adverse events.14,80 Since several studies12,30,44,51,56 were able to demonstrate a high 
sensitivity and specificity for intracranial aneurysmal detection for magnetic imaging using the 
three- dimensional, time-of-flight sequence angiography (3D, TOF MRA) at 3 Tesla, the pri-
mary use of the invasive DSA as a screening method is not necessary. The sensitivity of this 
imaging method was shown to range between 83% and 100%30,44,51 and its specificity was 
97%56 in several studies using large cohorts. Therefore scientific data shows that 3D TOF 
MRA is equally accurate and effective in the detection of unruptured intracranial aneurysms 
compared to DSA12 as well as a follow- up method in patients who had undergone endovas-
cular aneurysmal treatment.2 Currently, advances and ongoing research in imaging tech-
niques visualizing the vessel wall structure (additionally to assessing the lumen when using 
MRA) are made, using the so-called MR-vessel wall imaging (VWI) method.47 Since, as pre-
viously stated, inflammatory pathobiologic mechanisms are hypothesized to play a key role in 
whether or not rupture of an intracranial aneurysm will occur, this novel imaging technique 
(by suppressing the signals from blood and cerebrospinal fluid and detecting vessel wall sig-
nals) can assess more detailed the vessel wall structure.45 Scientific data linked circumferen-
tial wall enhancement to ruptured saccular aneurysms, whilst no enhancement at all seemed 
to be a strong indicator for a stable aneurysm. 17,43,46 However, not enough is understood yet 
about the histopathologic basis of this diverse pathology and the different facets of its 
presentation on VWI imaging.  
 
2.6. The clinical relevance of an association of BAV with intracranial aneurysms 
Since during embryogenesis the heart valves, the structures of the head and neck as well as 
the arterial system all develop from the same tissue, namely the neural crest73, one could 
hypothesize that a genetic defect affecting these tissues may be the underlying cause.63 
Therefore an association of bicuspid aortic valves not only with aortal aneurysmal disease 
but also intracranial aneurysms seems plausible, especially since a connective tissue defect 
is the key pathophysiologic feature in all three pathologies.  
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Investigating this possible association between BAV and intracranial aneurysms is of great 
clinical relevance since their early diagnosis and the detection of risk individuals is crucial. 
Twelve percent64 of patients with aneurysmal cerebral bleeding never even reach the hospi-
tal and stand a chance for treatment. The mortality rate (as aforementioned) is as high as 
65%79, and due to secondary brain damage half of the patients remain with permanent disa-
bilities.52 Neuropsychological deficits (e.g. cognitive dysfunction) are common, even in cases 
where the outcome is considered good.3,16 
The majority of intracerebral aneurysms are asymptomatic until the time of rupture. Death 
can occur within minutes and results from the mass effect of a massive subarachnoid haem-
orrhage or intracerebral bleeding depending on the location of the aneurysm. The high fatali-
ty and disability rate of subarachnoidal haemorrhage has already been mentioned before. 
There are also hypothesis, that the cardiorespiratory centre located within the brainstem is 
instantly depressed if reached by arterial blood with high pressure.42 Symptoms of a ruptured 
intracranial aneurysm may include any kind: resulting from a neurological deficit (cranial 
nerve deficits, motor and sensory deficits) or severe headache, neck stiffness, photophobia 
or an altered conscious or mental status.  
The diagnosis of an intracranial aneurysm can often only be done postmortem in patients 
where sudden collapse and death of unknown origin has occurred.7 
This underlines that only the identification of an asymptomatic intracranial aneurysm ahead 
of time and the assessment of its risk of rupture, are essential in granting the appropriate 
treatment. Only then, prophylaxis in the form of either interventional methods (clipping or 
endovascular coiling) to prevent rupture or monitoring, using MRI control scans at set time 
intervals can be done.  
Therefore the aim of this study was to look into the prevalence of aneurysms in patients with 
bicuspid aortic valves since this constitutes a connective tissue disorder, as well as to look 
into a possible association of the two pathologies in a German patient collective to improve 







3. Material and Methods 
In this prospective study, 60 patients with known congenital BAV who underwent cardiotho-
racic surgery were screened using MRI imaging for detection of an intracranial aneurysm. 
The aim was to establish the prevalence of intracranial aneurysms in patients with a congeni-
tal BAV in order to investigate a possible association of the two pathologies.  
The study was approved by the local ethics committee (ethics committee of the Saarland 
University Medical Center, Homburg, Germany, ethics vote no. 98/16) and obeys the laws of 
the declaration of Helsinki. Every single patient was explained carefully and in detail the aim, 
content and sequence of this study. Also every patient was informed that it is his or her right-
ful law to withdraw his or her consent at any point without reason and fear of any negative 
consequences (please also see the Addendum for detailed information). An informed con-
sent concerning the participation in this study as well as a data protection waiver form was 
signed by each patient. 
First, patients with congenital BAV from the contingent of the department of thoracic and car-
diovascular surgery of the Saarland University Medical Center, Homburg, Germany, were 
identified. Patients between the ages of 30 and 60 years with known congenital BAV, which 
had undergone valvular surgery at the department of thoracic and cardiovascular surgery of 
the Saarland University Medical Center, Homburg, Germany, were included. A lower age 
limit was chosen, since according to current medical data76, aneurysmal occurrence mainly 
starts at the age of 30 and in order to reduce comorbidities in our patient cohort, the upper 
age limit was set to be no older than 60 years.  
Patients that were in poor health condition, had a cardiac pacemaker, claustrophobia, preg-
nant females, patients with the implantation of a cochlear device or cranioplasty containing 
MRI incompatible and artefact susceptible content, were excluded. None of the BAV patients 
have had an intracranial aneurysm detected beforehand. However, the majority of patients 
(45 out of 60) presented with previous aortal aneurysmal disease. 29 patients (25 males, 4 
females) presented with both, a preexisting aortal aneurysm plus additional risk factors for 
aneurysmal development and 16 patients had solely known aortal aneurysms without any 
other comorbidities. These aneurysms were all located in the proximal part of the aorta as-
cendens, in a few extending from the aortic root. One patient has had previous dissection of 
the abdominal aorta. 
The patients were counselled concerning the screening for an intracranial aneurysm at the 
department of neurology, Saarland University Medical Center, Homburg, Germany.  
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An individual patient sheet was used for each patient where the current and previous medical 
history, clinical examination, inclusion and exclusion criteria, risk factors for aneurysmal dis-
ease, current medication and contact details of the doctor of choice for result transmission 
were documented.  
Aneurysmal risk factors were defined as age, gender, diagnosed arterial hypertension, diabe-
tes mellitus type II, coronary artery disease, current or previous nicotine consumption, alco-
hol abuse and preexisting aneurysmal disease, known connective tissue disease and preex-
isting aneurysmal disease.  
With every patient the possible finding of an asymptomatic intracranial aneurysm was dis-
cussed and careful assessment took place, whether the patient wanted to have knowledge of 
such a finding or not. This was document for every individual patient.  
Then a thorough neurological examination was performed and any neurological deficits 
found were precisely documented. Informed consent about the MRI investigation as such 
was sought.  
For aneurysmal detection a 3 Tesla MRI Scanner (Magnetom Skyra, Siemens Healthineers, 
Erlangen, Germany) was used to obtain a 3D MR TOF angiography. Additional screening 
sequences to detect blood degradation productions were added: T1 MPRAGE, T2 axial, T2* 
axial as well as a DWI sequence.  
All MRI imaging studies were reviewed by a neuroradiologist and neurologist as well as in-
dependently reviewed a second time by a neuroradiology specialist at the department of neu-
roradiology at the Saarland University Medical Center, Homburg, Germany. 
In cases of incidental imaging findings (e.g. cerebral infarction) where further medical inves-
tigation or therapy was needed, further neurological consultation was performed. 
The following table (table I) shows a more detailed characterization of the patient collective 
which was investigated, including their age, gender, previous aneurysmal disease, other pre-






Table I: Detailed description of age, sex, aneurysmal risk factors and intracranial aneurysm      

















1 47 m yes yes no 
2 30 m yes yes no 
3 33 m yes no no 
4 59 m no yes no 
5 54 m yes no no 
6 43 m no no no 
7 49 m yes yes no 
8 33 m no no no 
9 53 m yes yes no 
10 54 m yes yes no 
11 62 m yes yes no 
12 61 m no yes no 
13 44 m no no no 
14 45 f no yes no 
15 50 f yes yes no 
16 63 m yes yes no 
17 52 f yes yes no 
18 41 m yes yes no 
19 55 f yes yes no 
20 60 m yes no no 
21 69 m yes yes no 
22 75 m no yes no 
23 54 m yes yes no 
24 56 m no yes no 
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25 61 m yes yes no 
26 46 m yes no no 
27 31 f yes yes no 
28 59 m yes no no 
29 38 m no no no 
30 27 m no no no 
31 51 m no no no 
32 64 m yes yes no 
33 50 m no yes no 
34 47 m yes no no 
35 39 m yes no no 
36 69 m yes yes no 
37 46 m yes yes no 
38 50 m yes yes no 
39 51 m yes yes no 
40 57 m yes yes no 
41 24 m no no no 
42 57 m no yes no 
43 48 m yes no no 
44 49 m yes no no 
45 52 m yes no no 
46 69 m yes no no 
47 60 m yes no no 
48 36 m yes yes no 
49 41 m yes no no 
50 56 m yes no no 
51 61 m yes no no 
52 78 m yes yes no 
53 71 m yes yes no 






















55 53 m yes no no 
56 52 m no yes no 
57 60 m yes yes no 
58 64 m yes yes no 
59 50 m yes yes no 
60 73 m yes yes no 
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4. Results  
A total of 60 patients with BAV underwent MRI screening for the detection of an intracranial 
aneurysm. The mean age of this group was 51.6 years, 55 patients were of male and 5 of 
female gender. The assessment of aneurysmal risk factors revealed 33 patients with known 
arterial hypertension, 5 patients with diabetes mellitus type II, 10 patients with nicotine 
abuse, none with regular and excessive alcohol consumption and 5 patients with previous 
coronary artery disease. 
In 45 patients (41 male, 4 female) preexisting aneurysmal disease, mainly in the form of ei-
ther an aneurysm of the ascending aorta or aortic arch or previous dissection of the ab-
dominal aorta were found.  
29 patients (25 male, 4 female) presented with both, a preexisting aortal aneurysm plus addi-
tional risk factors for aneurysmal development. 16 patients had solely known aortal aneu-
rysms and 8 solely risk factors in their previous medical history. So, in total, only 7 out of the 
60 patients did not present with preexisting aortal aneurysms. All of them were male. 1 pa-
tient had known Marfan syndrome.  
For a detailed description of aneurysmal risk factors in this patient cohort please see table II. 
Two patients presented with neurological deficits which consisted of hypacusis of the right 
ear and resting tremor of both hands with the focus being on the left hand, including minimal 
rigor. These were not related to any intracranial pathology connected with an intracranial 
aneurysm or any other kind of connective tissue disease or with the previous aortic valve 
surgery. Furthermore, all together 12 patients presented with previous diseases: 3 patients 
have had a previous transitory ischemic attack, 5 patients suffered from atrial fibrillation, one 
patient had an essential tremor and 1 patient bladder cancer without known metastases at 
the time of screening.  
The incidental findings of the MRI screening of these 60 patients are listed in table III. 16 
showed cerebral microbleedings, 3 cerebral infarction, which had been clinically silent (one in 
the right media artery territory, one in both media artery territories and one in the left posteri-
or artery territory), one an arachnoid cyst, one with a lesion of unidentified origin in the brain-
stem, one with capillary telangiectasia, one with a subependymoma and one with an extra-
cranial aneurysm of the size of 9 mm of the left carotid artery.  So in conclusion, the majority 
of patients (26%) showed cerebral microbleedings and clinically silent cerebral infarction 
(5%). However, an intracranial aneurysm was not detected in this patient cohort. 
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Table II: Summary of the results of our patient collective 
Data of 60 patients screened  
no. of patients with BAV 60 
mean age 51.6 years 
M:F ratio 55:5 
arterial hypertension 33 (55.0 %) 
DM II 5 (8.3 %) 
nicotine abuse 11 (18.3 %) 
excessive alcohol none (0.0 %) 
connective tissue disease 1 (Marfan Syndrome) (1.7 %) 
neurological deficits 2 (3.3 %) 
preexisting aortal aneurysmal disease 
M:F ratio 
45 (75.0 %) 
41:4  
preexisting aneurysm + risk factor 
M:F ratio 
29 (48.3 %) 
25:4  
 
Table III: Incidental MRI findings in our patient collective 
Incidental MRI findings  
cerebral microbleedings 16 
cerebral infarction (clinically silent) 3 
arachnoid cyst 1 
capillary telangiectasia 1 
subependymoma 1 
extracranial aneurysm 1 





In this patient cohort with a bicuspid aortic valve no intracranial aneurysm was detected (0 
out of 60 patients). The general prevalence of unruptured intracranial aneurysm is 3.2 %.76 
This data is derived from the currently largest meta-analysis consisting of 68 studies on 83 
study populations, including 94 912 patients from 21 countries for a population characterized 
by a mean age of 50 years and consisting of 50% male patients.  
In medical literature the presence of dilatation of the ascending aorta or the aortic root con-
comitant to a BAV is suspected to be an indicator for the severity of connective tissue dis-
ease.63 If this is true, the majority of our patient cohort (45 patients) consists of patients with 
severe BAV disease - still no intracranial aneurysm could be detected. Another subgroup (29 
patients, 25 male and 4 female) had preexisting aneurysmal disease plus an additional risk 
factor for aneurysmal development. So, in this patient collective only 7 out of 60 patients 
were risk factor free and 53 patients presented with factors, presumably increasing their risk 
of intracranial aneurysmal development, additionally to their known congenital bicuspid aortic 
valve. This result does not support the hypothesis, that a congenital bicuspid aortic valve as 
a connective tissue disease increases the risk of intracranial aneurysm occurrence, at least 
not in this patient cohort. 
Magnetic resonance imaging was the preferred screening method, because of its high accu-
racy in aneurysmal detection and almost nonexistent associated risks. Compared to comput-
ed tomography imaging or digital subtraction angiography there is no radiation exposure. 
Furthermore, as aforementioned, the chosen imaging technique remains to be accurate and 
noninvasive. Digital subtraction angiography only remains to be a superior method concern-
ing the visualization of the morphology of a vascular malformation, but did not show to have 
an advantage concerning accuracy.12 No contrast media had to be infused, so the risk of an 
anaphylactic reaction was non-existent. Ethically it was particularly important to avoid high 
risk exposure of the patients, since undergoing this investigation was merely a dispensable 
screening process. 
The incidental MRI findings of this patient collective match with the common incidental MRI 
findings in medical literature. Literature describes that the majority of patients (76%) that un-
derwent cardiac surgery, especially if they had preexisting cardiovascular risk factors, show 
cerebral microbleeds. These are asymptomatic and no neurophysiological decline has ever 
been linked to this finding.35,55 The most frequent incidental findings on MRI scans in the 
general population are asymptotic brain infarcts, followed by benign primary tumors and 
arachnoid cysts.75 
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Capillary telangiectasia is defined as a cerebral vascular malformation alongside arteriove-
nous, venous and cavernous vascular malformations.42,48 It consists of multiple dilated ves-
sels in between healthy cerebral tissues and are often incidental findings on autopsies or 
MRI imaging.75 The majority is located in the pons.42 Even though in the majority of cases 
they do not seem to be associated with cerebral haemorrhage or any other kind of conse-
quence increasing mortality, there have been rare cases reported in medical literature, where 
capillary telangiectasia has been identified postmortem as the cause of a major brain 
bleed.8,38 Some authors implicate that the neural tissue during embryogenesis plays a role in 
the development of capillary telangiectasia.42 It remains unknown, if this finding constitutes 
just another incidental finding in this patient cohort or if there may be an association of capil-
lary telangiectasia and congenital bicuspid aortic valves. 
One patient presented with the finding of an extracranially located aneurysm of the size of 9 
mm of the left carotid artery. This raises the question, whether this constitute a further inci-
dental finding or is a clue for a possible association of congenital bicuspid aortic valves and 
aneurysmal disease. However, to completely clarify this question more systematically inves-
tigations on larger patient cohorts are necessary. 
However, there are studies with deviant results on this topic. Besides Schievink et al.63 
(2010), a more recent but retrospective study by Egbe et al.18 published in 2017 supports an 
association of BAV with intracranial aneurysms. In the study cohort of Schievink et al.63 6 out 
of 61 patients with BAV revealed an intracranial aneurysm upon screening (prevalence of 
9.8%). Three of these patients were of female and 3 of male gender. All together 20 women 
and 41 men were screened with a male to female ration of 38:17 with a mean age being 49.1 
years. Egbe et al.18 reviewed retrospectively 678 patients with BAV - making it the largest 
study on this topic so far - finding a prevalence of 7.7% (52 out of 678 patients). 198 patients 
were of female, 480 patients of male gender, the mean age was 57 years. Here a higher risk 
in patients with coarctation of the aorta, right-left cusp fusion and female gender were identi-
fied. Currently, to our knowledge, two more studies exist addressing this issue: one by Shau-
lov et al.66 (2012) including 56 patients and one by Goyal et al.27 (2015) with 217 patients. 
With a prevalence of 1.8%66 (1 out of 56 patients) and 0.6%27 (2 out of 317 patients) respec-
tively, both do not support an association between the two entities. However, it should be 
noted here, that the patient cohorts screened where different, therefore slightly altering their 
statement and interpretations compared to this study, Schievink’s and Egbe’s.  Shaulov et 
al.66 screened patients with aneurysmal subarachnoidal bleeding for the existence of bicus-
pid aortic valves, therefore investigating already ruptured intracranial aneurysms. Goyal et 
al.27 screened patients with known intracranial aneurysmal disease for the presence of a bi-
cuspid aortic valve.  
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Factors influencing our findings that might in part explain why our results did not show an 
association of the two entities, shall be discussed in the following. 
A limitation of our study is that the patient cohort with 60 patients is rather small. Even 
though 53 patients presented with factors, presumably increasing their risk of intracranial 
aneurysmal development (according to current medical knowledge) additionally to their 
known congenital bicuspid aortic valve, not a single intracranial aneurysm was detected. A 
larger cohort may be more ideal for comparison with the general population and therefore be 
more expressive. However, Schievink et al.63 were able to demonstrate a rather high preva-
lence of 9.8% investigating a small patient cohort compared to Egbe`s 7.7% when investigat-
ing much more (678) patients18. So, whether or not the small number of patients is the es-
sential factor remains unknown, however scientifically the result of a study with a larger pa-
tient cohort is more significant of course, always keeping in mind that it was done retrospec-
tively. 
The majority of patients (5 out of the 6) with BAV who had an intracranial aneurysm in 
Schievink’s63 cohort had a concomitant thoracic aortal aneurysm. And even though Goyal et 
al.27 were not able to show a significant association between BAV and intracranial aneuryms, 
but indeed an association of thoracic aortal aneurysms and intracranial aneurysms, this rais-
es the questions whether the high prevalence found by Schievink et al. is due to the fact that 
there was actually “just” an association of aortal and intracranial aneurysms, rather than with 
intracranial aneurysms and BAV. If so, this would make a coexistant aortal aneurysm the 
decisive factor for screening in patients with BAV. Contradicting this point is the fact, that in 
our study the majority of patients (45 out of 60) presented with a known aneurysm of the aor-
ta and still none of them had an intracranial aneurysm. On a side note it should be mentioned 
here, that our patient cohort constitutes a considerable patient number with aortal aneurysms 
that was screened for intracerebral aneurysmal occurrence, which may be a valuable adden-
dum to the existing scientific data. So, in conclusion, deducing from this contradicting scien-
tific data, to what extent thoracic aortal aneurysms are associated with intracranial aneu-
rysms and both in turn with bicuspid aortic valve disease remains unclear. 
Secondly, with 5 female and 55 male patients our patient cohort is gender biased. Since the 
incidence of unruptured intracranial aneurysms seems to be much higher in the female gen-
der with 6.0%76 (compared to the prevalence of 3% in the general population), this could 
have influenced our results of not finding an association. The gender bias in our study can 
simply be explained by the fact that the contingent of the department of thoracic and cardio-
vascular surgery, Saarland University Medical Center, Homburg, Germany consisted of a 
majority of male patients since generally the occurrence of congenital bicuspid aortic valves 
is much more common in the male gender5,19,31,41,57,58,77. Yet, Schievink et al.63 state that they 
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do not believe that their results were influenced by the risk factor of female sex, since in their 
cohort still more men than women were screened, which still resulted in a higher incidence of 
intracranial aneurysms compared to their control group. And even Egbe et al.18 with 480 pa-
tients being male and only 198 patients being female, had a gender bias for the male gender, 
which, however, given the large patient cohort of 678 patients may not play such a significant 
role. Having a gender bias in the opposite direction, Goyal et al.27 (with 80 males and 237 
females) still did not find an association of the two pathologies. Therefore the extent of the 
relevance of the gender bias is not certain. However, a comparison of the 5 female patients 
of this study with the prevalence in the general population is surely not sufficiently repre-
sentative, this is another limitation of this study.  
Generally, it should also be mentioned that the data76 generating the prevalence of unrup-
tured intracranial aneurysms in the general population, consists of unruptured intracranial 
aneurysms which have been detected by different diagnostic modalities. A fact that might 
alter prevalence data due to varying comparability of the diagnostic tools used. Autopsy stud-
ies, MRI imaging (with and without angiography) and intraarterial substraction angiography 
were included. Whilst retrospective autopsy studies seem to have a lower prevalence (pre-
sumably particularly, when it comes to aneurysms of small size), existent data suggests that 
the imaging modalities of substraction angiography and MRI angiography are relatively well 
comparable.12 Also no alterations of prevalence for aneurysmal detection were found, when 
MRI angiography was used as the initial imaging method.76  Additionally, minor differences in 
comparability might not be in grave play when investigating such a large patient cohort of 94 
912 patients.     
The results of this study (0 out of 60 patients) add in to the current inhomogeneous picture 
attempting to answer the question, whether or not bicuspid aortic valves are associated with 
intracranial aneurysmal disease. This becomes particularly evident when scrutinizing the four 
aforementioned and currently existing scientific investigations of variable sized patient co-
horts: Schievink et al. 63 (2010) with 61 patients, Shaulov et al. 66  (2012) with 56 patients, 
Goyal et al. 27 (2015) with 317 patients and Egbe et al.18 (2017) with 678 patients. The preva-
lence rates range between 0.6% and 9.8%.  Whilst the study with the largest patient cohort 
was able to show a significant prevalence, the second largest study showed the lowest prev-
alence of all four studies, with the remaining two (with similar patient numbers of 56 and 61 
patients compared with each other and with this study) showing quite discrepant prevalences 
with 1.8% and 9.8% respectively, regardless of their cohort number.  
Could this be due to BAV, being such a heterogeneous pathology? Epidemiologic, clinical, 
genetic and molecular data on the genesis of BAV aortopathy itself, still remains very patchy 
up to this date.75  This raises the question, if first further research is needed to clarify and 
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classify the pathogenesis of the aortopathy in BAV patients. Maybe only certain types of BAV 
aortopathy are associated with intracranial aneurysm predisposition and therefore the type of 
BAV is the decisive factor for which patients need to be screened or not. Underlining this 
hypothesis is evidence linking genetics particularly with the pathogenesis of the root pheno-
type of congenital BAV disease26 and that different BAV phenotypes differ in their associated 
risks with the arterial vessel system.25  
Based on their results, Egbe et al.18 propose a routine screening for intracranial aneurysms 
in patients with known bicuspic aortic valves. Since adverse aortic events are associated with 
BAV25,26 this along with screening for aneurysms at other locations (e.g. the aorta) seems to 
be a reasonable suggestion in order to guarantee maximum safety when treating patients 
with BAV. However, when discussing aneurysmal screening ethical aspects come into es-
sential play. Is it ethically correct to recommend screening for a pathology that is asympto-
matic and may remain so until the end of a lifetime? Should we use our advanced technical 
medical tools for the screening of a disease that might never become relevant for the patient 
and its knowledge might even unnecessarily worry the patient? Can we even recommend a 
medical treatment associated with the risk of complications and accept permanent neurologi-
cal deficits or even death from an intervention that might not even have been necessary?   
Especially when it comes for example to predictive genetic testing in Huntington`s disease - 
a progressive neurodegenerative disease combining motor, cognitive and psychiatric dys-
function- an ethically correct conduct is challenging for the treating physician. It is common 
consens that the knowledge of having a gene mutation that might generate a disease that is 
not curable and inevitably will lead to death, is subject to each individuals informed voluntary 
decision.1 This reflects the fact, that every human being has the right not to know.  
In my opinion, a general recommendation on whether or not patients with BAV should be 
routinely screened for aneurysmal disease or even for concomitant connective tissue diseas-
es cannot be given with good consciences according to currently available scientific data. A 
careful evaluation of every individual patient case, taking into account the patients prefer-
ences so an informed decision can be made together with the patient, is necessary.  
However there is sufficient evidence from a multitude of scientific data from which clear 
guidelines concerning the screening and treatment methods of unruptured intracranial aneu-
rysms were developed by the German Association of Neurology (DGN).  
In conclusion, this study did not confirm the assumption that an existing congenital bicuspid 
aortic valve increases the risk for the development of an intracranial aneurysm in this patient 
cohort. Nevertheless, the underlying key for answering this clinically relevant question might 
lie in further research on the complexity of BAV pathology itself. Only then, more investiga-
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tions of larger cohort studies might shed some light on the prevalence and association of 

























6. References:  
 
1. International Huntington Association and the World Federation of Neurology 
Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive 
test in Huntington's disease. J Med Genet 1994;31:555-9. 
2. Ahmed SU, Mocco J, Zhang X, Kelly M, Doshi A, Nael K, De Leacy R. MRA versus 
DSA for the follow-up imaging of intracranial aneurysms treated using endovascular 
techniques: a meta-analysis. J Neurointerv Surg 2019;11:1009-14. 
3. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after 
aneurysmal subarachnoid hemorrhage. Stroke 2010;41:e519-36. 
4. Austin G, Fisher S, Dickson D, Anderson D, Richardson S. The significance of the 
extracellular matrix in intracranial aneurysms. Ann Clin Lab Sci 1993;23:97-105. 
5. Basso C, Boschello M, Perrone C, Mecenero A, Cera A, Bicego D, Thiene G, De 
Dominicis E. An echocardiographic survey of primary school children for bicuspid aortic 
valve. Am J Cardiol 2004;93:661-3. 
6. Baxter BT. Heritable diseases of the blood vessels. Cardiovasc Pathol 2005;14:185-
8. 
7. Black M, Graham DI. Sudden unexplained death in adults caused by intracranial 
pathology. J Clin Pathol 2002;55:44-50. 
8. Bland LI, Lapham LW, Ketonen L, Okawara SH. Acute cerebellar hemorrhage 
secondary to capillary telangiectasia in an infant. A case report. Arch Neurol 1994;51:1151-4. 
9. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, Maurer G, Baumgartner H, Lang 
IM. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. 
Circulation 1999;99:2138-43. 
10. Bromberg JE, Rinkel GJ, Algra A, Greebe P, van Duyn CM, Hasan D, Limburg M, ter 
Berg HW, Wijdicks EF, van Gijn J. Subarachnoid haemorrhage in first and second degree 
relatives of patients with subarachnoid haemorrhage. BMJ 1995;311:288-9. 
11. Chambers WR, Harper BF, Jr., Simpson JR. Familial incidence of congenital 
aneurysms of cerebral arteries: report of cases of ruptured aneurysms in father and son. J 
Am Med Assoc 1954;155:358-9. 
12. Cirillo M, Scomazzoni F, Cirillo L, Cadioli M, Simionato F, Iadanza A, Kirchin M, Righi 
C, Anzalone N. Comparison of 3D TOF-MRA and 3D CE-MRA at 3T for imaging of 
intracranial aneurysms. Eur J Radiol 2013;82:e853-9. 
13. Darkwah Oppong M, Iannaccone A, Gembruch O, Pierscianek D, Chihi M, Dammann 
P, Koninger A, Muller O, Forsting M, Sure U, Jabbarli R. Vasospasm-related complications 
after subarachnoid hemorrhage: the role of patients' age and sex. Acta Neurochir (Wien) 
2018;160:1393-400. 
27 
14. Dawkins AA, Evans AL, Wattam J, Romanowski CA, Connolly DJ, Hodgson TJ, Coley 
SC. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive 
procedures. Neuroradiology 2007;49:753-9. 
15. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid 
haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J 
Neurol Neurosurg Psychiatry 2007;78:1365-72. 
16. Eagles ME, Tso MK, Macdonald RL. Cognitive Impairment, Functional Outcome, and 
Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg 
2019. 
17. Edjlali M, Gentric JC, Regent-Rodriguez C, Trystram D, Hassen WB, Lion S, Nataf F, 
Raymond J, Wieben O, Turski P, Meder JF, Oppenheim C, Naggara O. Does aneurysmal 
wall enhancement on vessel wall MRI help to distinguish stable from unstable intracranial 
aneurysms? Stroke 2014;45:3704-6. 
18. Egbe AC, Padang R, Brown RD, Khan AR, Luis SA, Huston J, 3rd, Akintoye E, 
Connolly HM. Prevalence and predictors of intracranial aneurysms in patients with bicuspid 
aortic valve. Heart 2017;103:1508-14. 
19. Emanuel R, Withers R, O'Brien K, Ross P, Feizi O. Congenitally bicuspid aortic 
valves. Clinicogenetic study of 41 families. Br Heart J 1978;40:1402-7. 
20. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and 
pathophysiological implications of a bicuspid aortic valve. Circulation 2002;106:900-4. 
21. Frosen J, Piippo A, Paetau A, Kangasniemi M, Niemela M, Hernesniemi J, 
Jaaskelainen J. Remodeling of saccular cerebral artery aneurysm wall is associated with 
rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004;35:2287-
93. 
22. Fukuda H, Sako K, Yonemasu Y. Coarctation of the descending aorta with aneurysm 
of the anterior communicating artery. Surg Neurol 1985;23:380-2. 
23. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, 
Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-4. 
24. Gawinecka J, Schonrath F, von Eckardstein A. Acute aortic dissection: pathogenesis, 
risk factors and diagnosis. Swiss Med Wkly 2017;147:w14489. 
25. Girdauskas E, Disha K, Raisin HH, Secknus MA, Borger MA, Kuntze T. Risk of late 
aortic events after an isolated aortic valve replacement for bicuspid aortic valve stenosis with 
concomitant ascending aortic dilation. Eur J Cardiothorac Surg 2012;42:832-7; discussion 7-
8. 
26. Girdauskas E, Disha K, Rouman M, Espinoza A, Borger MA, Kuntze T. Aortic events 
after isolated aortic valve replacement for bicuspid aortic valve root phenotype: 
echocardiographic follow-up study. Eur J Cardiothorac Surg 2015;48:e71-6. 
28 
27. Goyal MS, Gottumukkala R, Bhalla S, Kates A, Zipfel GJ, Derdeyn CP. Bicuspid 
aortic valves and thoracic aortic aneurysms in patients with intracranial aneurysms. 
Neurology 2015;84:46-9. 
28. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. Association of aortic dilation with 
regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol 
1992;19:283-8. 
29. Harrod CG, Batjer HH, Bendok BR. Deficiencies in estrogen-mediated regulation of 
cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm 
pathogenesis and rupture in menopausal and postmenopausal women. Med Hypotheses 
2006;66:736-56. 
30. Hiratsuka Y, Miki H, Kiriyama I, Kikuchi K, Takahashi S, Matsubara I, Sadamoto K, 
Mochizuki T. Diagnosis of unruptured intracranial aneurysms: 3T MR angiography versus 64-
channel multi-detector row CT angiography. Magn Reson Med Sci 2008;7:169-78. 
31. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 
2002;39:1890-900. 
32. Hoh BL, Rojas K, Lin L, Fazal HZ, Hourani S, Nowicki KW, Schneider MB, Hosaka K. 
Estrogen Deficiency Promotes Cerebral Aneurysm Rupture by Upregulation of Th17 Cells 
and Interleukin-17A Which Downregulates E-Cadherin. J Am Heart Assoc 2018;7. 
33. Inagawa T, Hirano A. Autopsy study of unruptured incidental intracranial aneurysms. 
Surg Neurol 1990;34:361-5. 
34. Investigators UJ, Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, 
Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T. The natural course of 
unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012;366:2474-82. 
35. Jeon SB, Lee JW, Kim SJ, Chung CH, Kwon SU, Choi CG, Choo SJ, Nah HW, Kim 
JS, Kang DW. New cerebral lesions on T2*-weighted gradient-echo imaging after cardiac 
valve surgery. Cerebrovasc Dis 2010;30:194-9. 
36. Kang HG, Kim BJ, Lee J, Kim MJ, Kang DW, Kim JS, Kwon SU. Risk Factors 
Associated With the Presence of Unruptured Intracranial Aneurysms. Stroke 2015;46:3093-
8. 
37. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid 
aortic valves are associated with aortic dilatation out of proportion to coexistent valvular 
lesions. Circulation 2000;102:III35-9. 
38. Kesserwan MA, Shakil H, Fong C, Provias JP. Hemorrhagic giant cerebral capillary 
telangiectasia resulting in death: Case report and literature review. Clin Neuropathol 2019. 
39. Kim ST, Brinjikji W, Kallmes DF. Prevalence of Intracranial Aneurysms in Patients 
with Connective Tissue Diseases: A Retrospective Study. AJNR Am J Neuroradiol 
2016;37:1422-6. 
29 
40. Kong WK, Regeer MV, Ng AC, McCormack L, Poh KK, Yeo TC, Shanks M, Parent S, 
Enache R, Popescu BA, Yip JW, Ma L, Kamperidis V, van der Velde ET, Mertens B, Ajmone 
Marsan N, Delgado V, Bax JJ. Sex Differences in Phenotypes of Bicuspid Aortic Valve and 
Aortopathy: Insights From a Large Multicenter, International Registry. Circ Cardiovasc 
Imaging 2017;10. 
41. Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 
cases. Am J Cardiol 1984;53:849-55. 
42. Leestema J. Forensic Neuropathology 2nd Edition. Taylor & Francis Group, Florida 
2009. 
43. Lehman VT, Brinjikji W, Mossa-Basha M, Lanzino G, Rabinstein AA, Kallmes DF, 
Huston J. Conventional and high-resolution vessel wall MRI of intracranial aneurysms: 
current concepts and new horizons. J Neurosurg 2018;128:969-81. 
44. Li MH, Cheng YS, Li YD, Fang C, Chen SW, Wang W, Hu DJ, Xu HW. Large-cohort 
comparison between three-dimensional time-of-flight magnetic resonance and rotational 
digital subtraction angiographies in intracranial aneurysm detection. Stroke 2009;40:3127-9. 
45. Mandell DM, Mossa-Basha M, Qiao Y, Hess CP, Hui F, Matouk C, Johnson MH, 
Daemen MJ, Vossough A, Edjlali M, Saloner D, Ansari SA, Wasserman BA, Mikulis DJ, 
Vessel Wall Imaging Study Group of the American Society of N. Intracranial Vessel Wall 
MRI: Principles and Expert Consensus Recommendations of the American Society of 
Neuroradiology. AJNR Am J Neuroradiol 2017;38:218-29. 
46. Matouk CC, Mandell DM, Gunel M, Bulsara KR, Malhotra A, Hebert R, Johnson MH, 
Mikulis DJ, Minja FJ. Vessel wall magnetic resonance imaging identifies the site of rupture in 
patients with multiple intracranial aneurysms: proof of principle. Neurosurgery 2013;72:492-6; 
discussion 6. 
47. Matsushige T, Shimonaga K, Mizoue T, Hosogai M, Hashimoto Y, Takahashi H, 
Kaneko M, Ono C, Ishii D, Sakamoto S, Kurisu K. Lessons from Vessel Wall Imaging of 
Intracranial Aneurysms: New Era of Aneurysm Evaluation beyond Morphology. Neurol Med 
Chir (Tokyo) 2019;59:407-14. 
48. McCormick WF. The pathology of vascular ("arteriovenous") malformations. J 
Neurosurg 1966;24:807-16. 
49. Messner B, Bernhard D. Bicuspid aortic valve-associated aortopathy: Where do we 
stand? J Mol Cell Cardiol 2019;133:76-85. 
50. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, Eidem B, 
Edwards WD, Sundt TM, 3rd, Enriquez-Sarano M. Incidence of aortic complications in 
patients with bicuspid aortic valves. JAMA 2011;306:1104-12. 
30 
51. Mine B, Pezzullo M, Roque G, David P, Metens T, Lubicz B. Detection and 
characterization of unruptured intracranial aneurysms: Comparison of 3T MRA and DSA. J 
Neuroradiol 2015;42:162-8. 
52. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case 
fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and 
region: a meta-analysis. Lancet Neurol 2009;8:635-42. 
53. Pachulski RT, Weinberg AL, Chan KL. Aortic aneurysm in patients with functionally 
normal or minimally stenotic bicuspid aortic valve. Am J Cardiol 1991;67:781-2. 
54. Park SC, Neches WH. The neurologic complications of congenital heart disease. 
Neurol Clin 1993;11:441-62. 
55. Patel N, Banahan C, Janus J, Horsfield MA, Cox A, Li X, Cappellugola L, Colman J, 
Egan V, Garrard P, Chung EML. Perioperative Cerebral Microbleeds After Adult Cardiac 
Surgery. Stroke 2019;50:336-43. 
56. Raaymakers TW, Buys PC, Verbeeten B, Jr., Ramos LM, Witkamp TD, Hulsmans FJ, 
Mali WP, Algra A, Bonsel GJ, Bossuyt PM, Vonk CM, Buskens E, Limburg M, van Gijn J, 
Gorissen A, Greebe P, Albrecht KW, Tulleken CA, Rinkel GJ. MR angiography as a 
screening tool for intracranial aneurysms: feasibility, test characteristics, and interobserver 
agreement. AJR Am J Roentgenol 1999;173:1469-75. 
57. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am 
J Cardiol 1970;26:72-83. 
58. Sabet HY, Edwards WD, Tazelaar HD, Daly RC. Congenitally bicuspid aortic valves: 
a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 
additional cases. Mayo Clin Proc 1999;74:14-26. 
59. Schafers HJ, Kunihara T, Fries P, Brittner B, Aicher D. Valve-preserving root 
replacement in bicuspid aortic valves. J Thorac Cardiovasc Surg 2010;140:S36-40; 
discussion S5-51. 
60. Schievink WI, Mokri B. Familial aorto-cervicocephalic arterial dissections and 
congenitally bicuspid aortic valve. Stroke 1995;26:1935-40. 
61. Schievink WI, Mokri B, Piepgras DG, Gittenberger-de Groot AC. Intracranial 
aneurysms and cervicocephalic arterial dissections associated with congenital heart disease. 
Neurosurgery 1996;39:685-9; discussion 9-90. 
62. Schievink WI, Parisi JE, Piepgras DG, Michels VV. Intracranial aneurysms in Marfan's 
syndrome: an autopsy study. Neurosurgery 1997;41:866-70; discussion 71. 
63. Schievink WI, Raissi SS, Maya MM, Velebir A. Screening for intracranial aneurysms 
in patients with bicuspid aortic valve. Neurology 2010;74:1430-3. 
64. Schievink WI, Wijdicks EF, Parisi JE, Piepgras DG, Whisnant JP. Sudden death from 
aneurysmal subarachnoid hemorrhage. Neurology 1995;45:871-4. 
31 
65. Schwartz MJ, Baronofsky ID. Ruptured intracranial aneurysm associated with 
coarctation of the aorta; report of a patient treated by hypothermia and surgical repair of the 
coarctation. Am J Cardiol 1960;6:982-8. 
66. Shaulov A, Leibowitz D, Rott D. Prevalence of bicuspid aortic valve in patients 
presenting with subarachnoid hemorrhage related to an intracerebral aneurysm. Int J Cardiol 
2012;157:142-3. 
67. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 
304 surgical specimens. J Thorac Cardiovasc Surg 2007;133:1226-33. 
68. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol 
2010;55:2789-800. 
69. Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small unruptured intracranial 
aneurysm verification study: SUAVe study, Japan. Stroke 2010;41:1969-77. 
70. Steinmetz H. S1 Leitlinie Unrupturierte intrakranielle Aneurysmen. Deutsche 
Gesellschaft für Neurologie Leitlinien 2012. 
71. Tulamo R, Frosen J, Hernesniemi J, Niemela M. Inflammatory changes in the 
aneurysm wall: a review. J Neurointerv Surg 2010;2:120-30. 
72. Turan N, Heider RA, Zaharieva D, Ahmad FU, Barrow DL, Pradilla G. Sex Differences 
in the Formation of Intracranial Aneurysms and Incidence and Outcome of Subarachnoid 
Hemorrhage: Review of Experimental and Human Studies. Transl Stroke Res 2016;7:12-9. 
73. TW S. Langman`s Medical Embryology 10th Edition. Lippincott, Philadelphia 2006. 
74. Tzemos N, Therrien J, Yip J, Thanassoulis G, Tremblay S, Jamorski MT, Webb GD, 
Siu SC. Outcomes in adults with bicuspid aortic valves. JAMA 2008;300:1317-25. 
75. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, 
Breteler MM, van der Lugt A. Incidental findings on brain MRI in the general population. N 
Engl J Med 2007;357:1821-8. 
76. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial 
aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic 
review and meta-analysis. Lancet Neurol 2011;10:626-36. 
77. Ward C. Clinical significance of the bicuspid aortic valve. Heart 2000;83:81-5. 
78. Wermer MJ, van der Schaaf IC, Algra A, Rinkel GJ. Risk of rupture of unruptured 
intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-
analysis. Stroke 2007;38:1404-10. 
79. Wiebers DO, Whisnant JP, Huston J, 3rd, Meissner I, Brown RD, Jr., Piepgras DG, 
Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-
Beckman GL, Torner JC, International Study of Unruptured Intracranial Aneurysms I. 
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and 
endovascular treatment. Lancet 2003;362:103-10. 
32 
80. Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Montanera W. 
Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures 
and review of the literature. Radiology 2003;227:522-8. 
81. Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E, Frosen J, 
Niemela M, Jaaskelainen J, Hernesniemi J, Tromp G. Familial intracranial aneurysms: an 






















7. Acknowledgements/ Publication 
 
Firstly, I would like to thank Prof. Dr. med. Klaus Faßbender for taking me under his wings 
and guiding me since my start in the field of neurology. 
To the neuroradiology team- without your support and close collaboration this work would not 
have been possible, a special thank you to Prof. Dr. med. Wolfgang Reith, Dr. med. Heiko 
Körner, Dr. med. Umut Yilmaz , Dr. med. Ruben Mühl-Benninghaus, Dr. med. Andreas, 
Simgen 
Furthermore I am very grateful for the chance of doing scientific work with Prof. Dr. med. 
Hans-Joachim Schäfers whose expertise, experience and scientific ideas have been essen-
tial for this work.  
Also, I would like to thank Daniel Rapp and Dipl.- Stat. Gudrun Wagenpfeil for her support of 
the statistical part of this scientific work. 
Finally, I want to express my gratitude to Dr. med. Jan Bürmann. Without his support, guid-
ance and encouragement every step along the way of this thesis and in clinical practice I 
would not be the kind of doctor I am today. 
And to my husband - there will never be enough words to express how grateful I am to have 






The results of this study will be submitted for publication with the title “Prevalence and asso-
ciation of intracranial aneurysms in patients with bicuspid aortic valve disease” in the Journal 






    Patienteninformation 
zur Teilnahme an der Studie zur Inzidenz und Assoziation intrakranieller 
Aneurysmata mit kongenitalen bikuspiden Aortenklappen 
 
Sehr geehrte Patientin, sehr geehrter Patient, 
sie befinden sich in kardiologischer Betreuung, da bei Ihnen von Geburt an eine bikuspide 
Aortenklappe vorliegt. Normalerweise besteht die Aortenklappe aus drei Segmenten, während 
sich bei bikuspiden Klappen aufgrund einer fehlenden Separation während der Embryonalzeit 
nur zwei funktionale Aortenklappen ausbildeten. Das Gewebe, aus welchem die Aortenklap-
pen bestehen ist dasselbe aus welchem die Gefäßwände der weiterführenden Gefäße der Aorta 
bestehen. Hierzu zählen auch die hirnversorgenden arteriellen Blutgefäße.  Häufig zeigen sich 
verbunden mit der Diagnose einer bikuspiden Aortenklappe  Gefäßwandauffälligkeiten an 
anderen Stellen des Gefäßsystems. Zu diesen Auffälligkeiten zählen auch sog. intrakranielle 
Aneurysmata. Hierbei handelt es sich um Gefäßwandausweitungen, welche mit einem erhöh-
ten Risiko einer Gehirnblutung einhergehen. Um dieser vorzubeugen kann die vorherige Di-
agnosestellung eines Aneurysmatas einen erheblichen prognostischen Nutzen haben.  
Da nach aktuellem Kenntnisstand eine Häufung intrakranieller Aneurysmata bei Patienten mit 
kongenitalen bikuspiden Aortenklappen vorliegt, würden wir Ihnen anbieten im Rahmen einer 
Studie  eine kernspintomographische Bildgebung des Gehirns und seiner Gefäße an der Uni-
versitätsklinik zu organisieren.  
Bei dieser Untersuchung handelt es sich um bildgebende Modalität, bei der mit Hilfe eines 
Magnetfeldes Radiowellen erzeugt werden, welche auf bestimmte Körperbereiche geschickt 
werden (in Ihrem Fall der Kopf) und die entstehenden Echosignale gemessen werden. Ein 
Computer erstellt daraus Querschnittbilder. Eine ergänzende Magnet- Resonanz- Angiogra-
phie ermöglicht es die Blutgefäße darzustellen. Für die Untersuchung werden Sie auf einer 
Liege in einer ca. 60 bis 80 cm großen Öffnung liegen. Laute Klopfgeräusche während der 
Untersuchung entstehen durch die elektromagnetische Schaltung und sind völlig normal, sie 
werden jedoch Ohrstöpsel sowie Kopfhörer erhalten. Die durchschnittliche Untersuchungszeit 
liegt zwischen 20 bis 40 Minuten. Obwohl es sich bei einer Kernspintomographie um eine 
harmlose, nichtinvasise Untersuchung handelt, können beispielsweise Schwellungen oder ein 
Wärmegefühl durch metallhaltige Farbstoffe von permanent Make-up oder Tätowierungen, 
Ohrgeräusche, welche zumeist nach der Untersuchung wieder verschwinden, können auftre-
ten. 
Es werden keine zusätzlichen, über die o.g. MRT Bildgebung hinausgehenden Untersuchun-
gen durchgeführt. 
Im Falle des Vorliegens einer Gefäßauffälligkeit wird ein ausführliches, interdisziplinäres 
Beratungsgespräch bzgl. des weiteren Vorgehens erfolgen. 
Zudem bitten wir Sie um Ihre Einwilligung, dass Ihre personenbezogenen Daten in pseudo-
nymisierter (verschlüsselter) Form für wissenschaftliche Zwecke verwendet werden dürfen 
(siehe beiliegende Datenschutzerklärung). 
Ein Aussteigen aus dieser Studie ist für Sie ohne Angaben von Gründen jederzeit möglich. 
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    Datenschutzerklärung 
 
Inzidenz und Assoziation intrakranieller Aneurysmata mit kongenitalen bi-
kuspiden Aortenklappen 
 
Mir, ………………………………………………………………………………………………………, ist bekannt, dass bei dieser 
klinischen Verlaufsbeobachtung personenbezogene Daten, insbesondere medizinische Befunde, über 
mich erhoben, gespeichert und ausgewertet werden sollen. Die Verwendung der Angaben über mei-
ne Gesundheit erfolgt nach den gesetzlichen Bestimmungen und setzt vor der Teilnahme an der Stu-
die folgende freiwillig abgegebene Einwilligungserklärung voraus: 
 
Einwilligung zum Datenschutz 
Ich willige ein, dass im Rahmen dieser klinischen Studie erhobene Daten, insbesondere Angaben über 
meine Gesundheit in Papierform und auf elektronischen Datenträgern in der Universitätsklinik des 
Saarlandes, Klinik für Neurologie sowie Klinik für Neuroradiologie aufgezeichnet werden. Ich willige 
ein, dass diese Daten in pseudonomysierter (verschlüsselter) Form für wissenschaftliche Zwecke und 
für die Veröffentlichung auf Kongressen oder in wissenschaftlichen Fachzeitschriften verwendet 
werden können. 
Die Einwilligung zur Erhebung und Verarbeitung meiner personenbezogenen Daten, insbesondere 
der Daten über meine Gesundheit,  ist widerruflich.  Ich bin bereits darüber aufgeklärt worden, dass 
ich jederzeit die Teilnahme an der klinischen Prüfung beenden kann. Im Fall eines solchen Widerrufs 
meiner Erklärung an der Studie teilzunehmen habe ich das Recht die Löschung meiner bis dahin er-
hobenen Daten ohne vorherige Prüfung zu verlangen. 
Ich willige ein, dass meine Daten nach Beendigung oder Abbruch der Prüfung mindestens 10 Jahre 
aufbewahrt werden, wie es die gesetzlichen Vorschriften vorsehen. Danach werden meine perso-
nenbezogenen Daten gelöscht. 
Falls ich meine Einwilligung, an dieser Studie teilzunehmen widerrufe, müssen alle Stellen, die meine 
personenbezogenen Daten, insbesondere Gesundheitsdaten, gespeichert haben, diese unverzüglich 
löschen. 
Homburg, den ……………………………………………. 
 
…………………………………………………………………………………………….. 
Name des Patienten und Unterschrift 
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Patient: …………………………………………………………………   Datum: 
Geb.: ……………………………………………………………………   Ärztin: B. Schmidl 








 o Herzschrittmacher 
 o Cochleaimplantat 
 o Klaustrophobie 
 o Schwangerschaft 
Risikofaktoren: 
 o Alter: 
 o Weibliches Geschlecht 
 o Arterieller Hypertonus/ RR Medikation 
 o Diabetes mellitus Typ II 
 o Koronare Herzkrankheit 
 o Ex- oder aktueller Nikotinabusus 
 o Übermäßiger Alkoholkonsum 
















 o vorläufiger Befund bereits mitgeteilt, endgültigen Befund nachschicken 
 o noch kein Befund mitgeteilt 
Intrakranielles Aneurysma im endgültigen cMRT Befund: 
 o ja, Beratungstermin am: 



















Aus datenschutzrechtlichen Gründen wurde der Lebenslauf für die Veröffentlichung entfernt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
